Health Condition 1: H251- Age-related nuclear cataract
Conditions
Interventions
Intervention1: POSTERIOR SUBTENON TRIAMCINOLONE ACETONIDE (40 MG/ML): Single injection of 0.5 mL (20 mg) triamcinolone acetonide administered in the posterior subtenon space at the end of small incisi
Sponsors
Sri Devaraj Urs Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Age more than 40 years Diagnosed with operable age-related cataract Undergoing uncomplicated SICS with posterior chamber IOL implantation
Exclusion criteria
Exclusion criteria: Pre-existing glaucoma or ocular hypertension History of uveitis or intraocular inflammation Complicated cataract like traumatic, subluxated, or mature cataract with phacolytic uveitis) Intraoperative complications like posterior capsular rupture, vitreous loss Systemic conditions affecting ocular inflammation like uncontrolled diabetes mellitus, autoimmune disorders Known allergy to corticosteroids Presence of corneal opacity or dystrophy affecting examination or IOP measurement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of postoperative anterior chamber inflammation (cells and flare) on POD 1, 7, and 30Timepoint: Postoperative day 1, 7, and 30 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in IOP from baseline Visual acuity improvement Incidence of adverse effects like steroid-induced IOP rise, subconjunctival hemorrhage Patient compliance & convenienceTimepoint: Postoperative day 1, 7, & 30 | — |
Countries
India
Contacts
Public ContactYeddula Venkata Rohith Reddy
Sri Devaraj Urs Medical College
Outcome results
None listed